Company intelligence / Profile preview

WebOligos

Evry, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

WebOligos was a French biotechnology company specializing in the custom synthesis of oligonucleotides and genomic services. Based in the Genopole biocluster in Evry, the company provided high-quality DNA and RNA synthesis for research and diagnostic applications. WebOligos was known for its efficient online ordering system and rapid turnaround times for custom sequences. In 2005, the company was acquired by the Belgian life sciences group Eurogentec to bolster its market share in France and enhance its manufacturing capacity.

Modalities: Synthetic oligonucleotide
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on WebOligos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WebOligos.

Explore the full profile